The bill revises requirements for prescribing Schedule II controlled dangerous substances through telemedicine in New Jersey. It allows healthcare providers to remotely deliver health services using telemedicine or telehealth, provided they are licensed in the state and meet regulatory requirements. The bill specifies conditions for using interactive real-time audio/visual technology, allowing exemptions for certain cases like minors, patients in specific medical situations, or those with substance use disorder. It also outlines the need for maintaining patient records, ensuring the same standard of care in telemedicine, and prompts relevant boards to adopt rules for telemedicine and telehealth services. The bill will take effect immediately once enacted.